M. N. Khagazheeva
Blokhin National Medical Research Center of Oncology
Russian Federation

Madina N. Khagazheeva, Oncologist of the Department of Antitumor Drug Therapy No. 3, Department of Drug Therapy, Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522

E. V. Reutova
Blokhin National Medical Research Center of Oncology
Russian Federation

Elena V. Reutova, Cand. Sci. (Med.), Senior Researcher, Oncologist of the Department of Antitumor Drug Therapy No. 3, Department of Drug Therapy, Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522

D. I. Yudin
Blokhin National Medical Research Center of Oncology
Russian Federation

Denis I. Yudin, Cand. Sci. (Med.), Senior Researcher, Oncologist of the Department of Antitumor Drug Therapy No. 3, Department of Drug Therapy, Trapeznikov Research Institute of Clinical Oncology

24, Kashirskoye Shosse, Moscow, 115522

V. V. Breder
Blokhin National Medical Research Center of Oncology
Russian Federation

Valery V. Breder, Dr. Sci. (Med.), Head of the Department of Drug Therapy, Oncologist of the Department of Antitumor Drug Therapy No. 3, Trapeznikov Research Institute of Clinical Oncology 

24, Kashirskoye Shosse, Moscow, 115522

K. K. Laktionov
Blokhin National Medical Research Center of Oncology; Pirogov Russian National Research Medical University
Russian Federation

Konstantin K. Laktionov, Corr. Member RAS, Dr. Sci. (Med.), First Deputy Director, Head of the Department of Antitumor Drug Therapy No. 3, Department of Drug Therapy, Trapeznikov Research Institute of Clinical Oncology, Blokhin National Medical Research Center of Oncology; Professor of the Department of Oncology and X-ray Therapy, General Medicine Faculty, Pirogov Russian National Research Medical University

24, Kashirskoye Shosse, Moscow, 115522; 
1, Ostrovityanov St., Moscow, 117513